Quản lý điều trị hiện tại của bệnh thận tiểu đường

Hasslacher C, Ritz E, Hypertonie and diabetes mellitus. Internist (Berlin) 31:180–190, 1990 Kleophas W, Voitz T, Messner H, Gries FA, Diabetische Nephropathie. Fortschr Med 108:309–312, 1990 Mogensen CE, Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 31:673–689, 1987 Mogensen CE, Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. New Engl J Med 310:356–360, 1984 Viberti GC, Jarrett RJ, Mahmud U, Hill RD, Argyropoulos A, Keen H, Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet I:1430–1432, 1982 Steffes MW, Mauer SM, Diabetic nephropathy: a disease causing and complicated by hypertension. Clin Chem 37/10 (B): 1838–1842, 1991 Eggers PW, Effect of transplantation on the Medicare end-stage renal disease program. New Engl J Med 318:223–229, 1988 The Kroc Collaborative Study Group, Blood glucose control and the evolution of diabetic retinopathy and albuminuria. New Engl J Med 311:365–372, 1984 The Kroc Collaborative Study Group, Collaborative studies of the effects of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. Diabetes 34 [Suppl 3]: 87–89, 1985 Feldt-Rasmussen B, Mathiesen ER, Deckert T, Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet II:1300–1304, 1986 Reichard P, Rosenquist U, Nephropathy is delayed by intensified insulin treatment in patients with insulin-dependent diabetes mellitus and retinopathy. J Intern Med 226:81–87, 1989 Feldt-Rasmussen B, Mathiesen ER, Jensen T, Lauritzen T, Deckert T, Effect of improved metabolic control on loss of kidney function in type I (insulin-dependent) diabetic patients: an update of the Steno studies. Diabetologia 34:164–170, 1991 The Diabetes Control and Complications Trial Research Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 329:977–986, 1993 Dahl-Jörgensen K, Björk T, Kierulf P, Sandvik L, Bangstad HJ, Hanssen KF, Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus. Kidney Int 41:920–923, 1992 Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM, Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 241:F85–F93, 1981 Wen S-F, Huang T-P, Moorthy AV, Effects of low protein diet on experimental diabetic nephropathy in the rat. J Lab Clin Med 106:589–597, 1985 Walker JD, Bending JJ, Dodds RA, Mattock MB, Murrells TJ, Keen H, Viberti GC, Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet II:1411–1415, 1989 Zeller K, Whittaker E, Sullivan L, Raskin P, Jacobson HR, Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. New Engl J Med 324:78–84, 1991 Brouhard BH, LaGrone L, Effect of dietary protein restriction on functional renal reserve in diabetic nephropathy. Am J Med 89:427–431, 1990 Evanoff GV, Thompson CS, Brown J, Weinmann EJ, The effect of dietary protein restriction on the progression of diabetic nephropathy. Arch Intern Med 147:492–495, 1987 Evanoff GV, Thompson CS, Brown J, Weinmann EJ, Prolonged dietary protein restriction in diabetic nephropathy. Arch Intern Med 149:1129–1133, 1989 Cohen D, Dodds R, Viberti G, Effect of protein restriction in insulin dependent diabetics at risk of nephropathy. BMJ 294: 795–798, 1987 Marre M, Chatellier G, Leblanc H, Guyene TT, Menard J, Passa P, Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ 297: 1092–1095, 1988 Marre M, Leblanc H, Suarez L, Guyenne T-T, Menard J, Passa P, Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. BMJ 294:1448–1452, 1987 Melbourne Diabetic Nephropathy Study Group, Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. BMJ 302: 210–216, 1991 Cook J, Daneman D, Spino M, Sochett E, Perlman K, Balfe JW, Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitus. J Pediatr 117:39–45, 1990 Mimram A, Insua A, Ribstein J, Bringer J, Monnier L, Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy. Diabetes Care 10:850–853, 1988 Mathiesen ER, Hommel E, Giese J, Parving H-H, Efficacy of captopril in postponing nephropathy in normotensive insulin-dependent diabetic patients with microalbuminuria. BMJ 303: 81–87, 1991 Christensen CK, Mogensen CE, The course of incipient diabetic nephropathy: studies of albumin excretion and blood pressure. Diabetic Med 2:97–102, 1985 Gambardella S, Frontoni S, Felici MG, Spallone VB, Gargiulo P, Morano S, Menzinger G, Efficacy of antihypertensive treatment with indapamide in patients with nontinsulin-dependent diabetes and persistent microalbuminuria. Am J Cardiol 65: 46H-50H, 1990 Baba T, Murabayashi S, Takebe K, Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type II (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial. Diabetologia 32:40–44, 1989 Pedersen MM, Hansen KW, Schmitz A, Sorensen K, Christensen CK, Mogensen CE, Effects of ACE inhibition supplementary to beta blockers and diuretics in early diabetic nephropathy. Kidney Int 41:883–890, 1992 Parving H-H, Hommel E, Nielsen MD, Giese J, Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy, BMJ 299:533–536, 1989 Mogensen CE, Long term antihypertensive treatment inhibiting progression of diabetic nephropathy. BMJ 285:685–688, 1982 Parving H-H, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA, Effect of antihypertensive treatment on kidney function in diabetic nephropathy. BMJ 294:1443–1447, 1987 Parving H-H, Smidt UM, Mathiesen ER, Hommel E, Ten year experience with antihypertensive treatment in diabetic nephropathy. Diabetologia 34 [Suppl 2]: A38, 1991 Parving H-H, Hommel E, Smidt UM, Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy, BMJ 297:1086–1091, 1988 Björk S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M, Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. BMJ 293:471–474, 1986 Björk S, Mulec H, Johnsen SA, Norden G, Aurell M, Renal protective effect of enalapril in diabetic nephropathy. BMJ 304: 339–343, 1992 Grönhagen-Riska C, Honkanen E, Metsärinne K, Rosenlöf K, Tikkanen I, Fyhrquist F, ACE-inhibition versus conventional antihypertensive treatment (β blockade) in diabetic nephropathy. Am J Hypertens 3:67A, 1990 Lewis EJ, Hunsicker LG, Bain R, Rohde RD, The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. New Engl J Med 329:1459–1462, 1993 Hora K, Oguchi H, Furukawa T, Hora K, Tokunaga S, Effect of a selective thromboxane synthetase inhibitor OKY-046 on experimental diabetic nephropathy. Nephron 56:297–305, 1990 Jensen PK, Steven K, Blaehr H, Christiansen JS, Parving H-H, Effects of indomethacin on glomerular hemodynamics in experimental diabetes. Kidney Int 29:490–495, 1986 Mathiesen ER, Hommel E, Olsen UB, Parving H-H, Elevated urinary prostaglandin excretion and the effect of indomethacin on renal function in incipient diabetic nephropathy. Diabetic Med 5:145–149, 1987 Rudberg S, Sätterströ G, Dahlquist R, Dahlquist G, Indomethacin but not metoprolol reduces exercise-induced albumin excretion rate in type 1 diabetic patients with microalbuminuria. Diabetic Med 10:460–464, 1993 Oates PJ, Ellery CA, Davis KM, Guzzie DN, Inskeep PB, Aldose reductase inhibitor Zopolrestat dose-dependently reduces albuminuria in streptozocin-diabetic rats. Diabetes 42 [Suppl 1]: 157A, 1993 Blohme G, Smith U, Aldose reductase inhibition reduces urinary albumin excretion rate in incipient diabetic nephropathy. Diabetologia 32:476A, 1989 Anderson S, Rennke HG, Brenner BM, Nifedipine versus fosinopril in uninephrectomized diabetic rats. Kidney Int 41:891–897, 1992 Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM, Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925–1930, 1986 Aizawa T, Suzuki S, Asawa T, Komatsu M, Shigematsu S, Okada N, Katakura M, Hiramatsu K, Shinoda T, Hashizume K, Takasu N, Yamada T, Masaoka Y, Mimura M, Takahashi H, Shimizu K, Honda Z, Dipyridamole reduces urinary albumin excretion in diabetic patients with normo-or microalbuminuria. Clin Nephrol 33:130–135, 1990